about
Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux diseaseWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesActive detergent-solubilized H+,K+-ATPase is a monomerProton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis.Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients.Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs.Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy.Human Intestinal Barrier Function in Health and DiseaseProton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancerEvidence-based support for the use of proton pump inhibitors in cancer therapyAttitude and Knowledge of Indian Emergency Care Residents towards Use of Proton Pump Inhibitors.Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy.Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis.The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer?Microscopic Colitis: What Do We Know About Pathogenesis?Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Hypoxia and Its Acid-Base Consequences: From Mountains to Malignancy.Rabeprazole exhibits antiproliferative effects on human gastric cancer cell lines.The stereoselectivity of CYP2C19 on R- and S-isomers of proton pump inhibitors.Omeprazole induces gastric transmucosal permeability to the peptide bradykinin.pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors.Impact of Gastric H+/K+-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects.Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board.Water pathways in the bacteriorhodopsin proton pump.Pharmacokinetic-Guided Dosing of New Oral Cancer Agents.Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors.
P2860
Q24203004-A6E66EED-C43C-4EA3-A697-20F0763491AEQ26991991-EFDEA109-1431-4DB5-9F7C-BC34E3CEF38CQ28276805-96DF2445-5640-4A5B-B2A1-A36361DA9DC4Q30620638-DD3902AB-DE3B-4134-856D-F86D81E272CCQ33564258-6A0633B5-621F-49D4-AB34-6337C0C73C96Q33688340-B5ECADE2-835C-4830-B313-0FB66BB64B97Q33698543-4B853B5D-3428-4755-A077-A75FE4893AB3Q34573748-DAD7D1B8-41B8-4DC4-B25E-18E41BFDDD69Q34679342-59AA32D8-2162-4C02-88D0-39761BA636D8Q35072261-59F1E356-10E3-4241-8E8F-96C42E999DA5Q35987082-A670D6BA-FDB1-499D-8CC1-7C92A3F094CDQ36310900-7190C259-D33D-42BC-BF46-5DDBDF956A03Q36979081-E7C10339-DC77-4669-8FE1-00459D51D1D4Q37748935-7991EA53-3954-4FFC-9AFB-34653DD14696Q37986308-A91139FD-C930-4539-A84F-E7BBFB0FC834Q38093799-8254E941-0D4B-461F-999B-DA7CD2691B1DQ38198997-8099EAB7-4283-47FD-8C74-8014F6803D51Q38623461-8BAB3480-A770-41A1-92FC-499D2AD1F86BQ38865456-55CC3FB1-A394-4B14-A31E-C44A674F05D0Q38876598-3F5DAA2A-136A-4B21-AC15-F0F12553033CQ38958255-7F6957B7-7A0B-48C1-A04A-AF88414DAE2BQ39292057-2633B267-6F0B-41AF-8425-21CA1593F082Q39529999-80223054-5429-43FA-80D1-1B42885BE18FQ39781678-4CDFF2A5-2845-4322-8EBA-415A1D8269E3Q41779445-CE48558A-96E4-485A-8164-BD88B0F0E1CDQ42364580-6C9D16E2-D24F-46E2-83EC-8641B5ECC6A1Q45822477-17417B1F-5EFE-438D-A4B6-D6468DFEF0C7Q46498771-F34BC44E-B4D4-45D8-B603-14DC69650015Q47969048-7B5ED91D-5B1A-4340-80CD-F174680BD994Q48552373-422CAA55-2F48-432D-BD3F-C6B121C717D2Q50921927-CAC220D2-C5EC-491C-B5CC-76AB1ADA4870
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proton pump inhibitors: actions and reactions.
@en
Proton pump inhibitors: actions and reactions.
@nl
type
label
Proton pump inhibitors: actions and reactions.
@en
Proton pump inhibitors: actions and reactions.
@nl
prefLabel
Proton pump inhibitors: actions and reactions.
@en
Proton pump inhibitors: actions and reactions.
@nl
P2093
P1433
P1476
Proton pump inhibitors: actions and reactions
@en
P2093
Christopher P Farrell
David Rudolph
James J Thornton
Jillan Bellows
Keith R Kearney
Kevin R Wolov
Lisa J Murray
Melissa Gabello
P304
P356
10.1016/J.DRUDIS.2009.03.014
P50
P577
2009-04-08T00:00:00Z